Acquisition of Novus Med

​“Novus Med is an excellent complement to HSL Group’s existing presence and customer offering within both the surgical field and out-patient departments in the UK. With this acquisition, we are adding new and innovative technologies in minimally invasive surgery and becoming a more comprehensive partner to the hospitals in the country. We are pleased to welcome the professional team from Novus Med, who, with their commitment to excellence and improving patient outcomes will fit very well with HSL Group and the rest of the Asker family”, says Johan Falk, CEO Asker Healthcare Group. 

​Novus Med is based in the UK, has 12 employees, and generated revenue of approximately SEK 80m in the past financial year ending in June 2025.

The acquisition is a bolt-on to HSL Group and is expected to contribute positively to the group’s EBITA margin.

For further information, please contact:
Emma Rheborg, Head of Communication Asker Healthcare Group
Phone: +46 73 313 62 17
E-mail: [email protected]

Asker Healthcare Group is a partner to caregivers and patients across Europe providing medical products and solutions. We build and acquire leading companies that together support the healthcare system to improve patient outcomes, reduce total cost of care and ensure a fair and sustainable value chain. We are a European healthcare group that combines the entrepreneurial drive of strong local companies, with the abilities and collected knowledge of a large group – driving progress in the healthcare sector. The group has more than 4 500 employees in 18 countries and revenues amounting to SEK 16 billion.